PTEN and neuroblastoma: PREX2a inhibits Pten activity itself, and the phenotype resulting from loss of PREX2a regulation by miR-338-3p should resemble the one resulting from loss of Pten. Prior studies have already shown miR-338-3p’s inhibition of PREX2a is crucial in suppression of neuroblastoma proliferation [43].